REDWOOD PHARMA AB:
* REDWOOD PHARMA SIGNS AGREEMENT REGARDING GMP PRODUCTION
* SIGNED AN AGREEMENT WITH CARBOGEN AMCIS
* CARBOGEN AMCIS WILL AVAIL REDWOOD PHARMA PRODUCTION OF NEW DRUG CANDIDATE RP101 FOR SUBSEQUENT CLINICAL TRIAL. Source text for Eikon: Further company coverage: (Gdynia Newsroom)
